Literature DB >> 11033415

The nitroxide tempol induces oxidative stress, p21(WAF1/CIP1), and cell death in HL60 cells.

M B Gariboldi1, V Rimoldi, R Supino, E Favini, E Monti.   

Abstract

The antiproliferative effect of Tempol, a stable nitroxide free radical, was investigated on the p53-negative human leukemia cell line HL60. A concentration- and time-dependent inhibition of cell growth was observed that appears to be due to induction of apoptosis. Involvement of oxidative stress is indicated by a concentration-dependent increase in intracellular peroxides and a parallel decrease in total cellular glutathione; in addition, increased survival rates were observed in cells simultaneously treated with Tempol and the antioxidant N-acetylcysteine. Tempol did not affect the relative levels of Bax and Bcl2, whereas p21(WAF1/CIP1) was enhanced in a concentration- and time-dependent fashion; this effect was partially inhibited by N-acetylcysteine, was maintained for up to 8 h after Tempol removal, and seemed to depend on continuing protein synthesis. The increase in p21(WAF1/CIP1) was accompanied by a parallel accumulation of cells in the G(1) phase of the cycle and by a decrease in the 110 kDa form of pRb. Our results suggest that p53-independent induction of p21(WAF1/CIP1) mediates the antiproliferative effect of Tempol; on the basis of this observation, the nitroxide could be proposed as an useful adjunct to the treatment of p53-deficient tumors, which are often refractory to standard chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11033415     DOI: 10.1016/s0891-5849(00)00347-6

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  14 in total

Review 1.  Hematopoietic Stem Cells: Normal Versus Malignant.

Authors:  Dustin Carroll; Daret K St Clair
Journal:  Antioxid Redox Signal       Date:  2017-12-20       Impact factor: 8.401

2.  [Effect of the chemoprotectant tempol on anti-tumor activity of cisplatin].

Authors:  Shuangyan Ye; Sisi Zeng; Mengqiu Huang; Jianping Chen; Xi Chen; Pengfei Xu; Qianli Wang; Wenwen Gao; Bingsheng Yang; Bingtao Hao; Wenhuan Huang; Qiuzhen Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-08-30

Review 3.  Effects of tempol and redox-cycling nitroxides in models of oxidative stress.

Authors:  Christopher S Wilcox
Journal:  Pharmacol Ther       Date:  2010-02-11       Impact factor: 12.310

Review 4.  The chemistry and biology of nitroxide compounds.

Authors:  Benjamin P Soule; Fuminori Hyodo; Ken-Ichiro Matsumoto; Nicole L Simone; John A Cook; Murali C Krishna; James B Mitchell
Journal:  Free Radic Biol Med       Date:  2007-03-12       Impact factor: 7.376

5.  Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy.

Authors:  Zhuo Zhang; Mao Li; Hui Wang; Sudhir Agrawal; Ruiwen Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-16       Impact factor: 11.205

6.  Nitroxide TEMPO: a genotoxic and oxidative stress inducer in cultured cells.

Authors:  Xiaoqing Guo; Roberta A Mittelstaedt; Lei Guo; Joseph G Shaddock; Robert H Heflich; Anita H Bigger; Martha M Moore; Nan Mei
Journal:  Toxicol In Vitro       Date:  2013-03-18       Impact factor: 3.500

7.  Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin.

Authors:  Raffaella Ravizza; Marzia B Gariboldi; Laura Passarelli; Elena Monti
Journal:  BMC Cancer       Date:  2004-12-15       Impact factor: 4.430

Review 8.  Nitroxides as Antioxidants and Anticancer Drugs.

Authors:  Marcin Lewandowski; Krzysztof Gwozdzinski
Journal:  Int J Mol Sci       Date:  2017-11-22       Impact factor: 5.923

9.  Enhanced susceptibility of cyclin kinase inhibitor p21 knockout mice to high fat diet induced atherosclerosis.

Authors:  Ashwani K Khanna
Journal:  J Biomed Sci       Date:  2009-07-15       Impact factor: 8.410

10.  A highly cytotoxic modified paullone ligand bearing a TEMPO free-radical unit and its copper(II) complex as potential hR2 RNR inhibitors.

Authors:  Anatolie Dobrov; Simone Göschl; Michael A Jakupec; Ana Popović-Bijelić; Astrid Gräslund; Peter Rapta; Vladimir B Arion
Journal:  Chem Commun (Camb)       Date:  2013-11-04       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.